Published in:
Open Access 01-12-2014 | Erratum
Erratum to: BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study
Published in: BMC Cancer | Issue 1/2014
Login to get accessExcerpt
After publication of this Research Article [1], we noted errors in Table 1, and in the rate of thromboembolic events (page 7). Specifically, in Table 1 the percentage of female and male patients were incorrectly given as 7% and 3% respectively. The correct figures are 48.6% female and 51.4% male (please see a corrected version of Table 1 below, and the Additional file 1). The correct rate of thromboembolic events is 3.49% (originally stated as 3.55%).
Table 1
Patient demographics
|
Characteristic
|
Value
|
|---|---|
|
Age, mean ± SD (years)
|
66.49 ± 11.77
|
|
Patients with solid tumours, mean (years)
|
65.76
|
|
Patients with lymphoma, mean (years)
|
68.59
|
|
Patients with myeloma, mean (years)
|
70.65
|
|
Female (%)
|
48.6
|
|
Male (%)
|
51.4
|
|
Hb, mean ± SD (g/dL)
|
9.59 ± 0.88
|
|
sBP, mean ± SD (mmHg)
|
125.75 ± 14.48
|
|
dBP, mean ± SD (mmHg)
|
74.18 ± 9.79
|
|
Malignancies, n (%)
|
2310 (100)
|
|
Solid tumours, n (%)
|
1838 (79.57)
|
|
Lymphoma, n (%)
|
301 (13.03)
|
|
Myeloma, n (%)
|
171 (7.40)
|
|
Height, mean ± SD (cm)
|
166.35 ± 8.72
|
|
Weight, mean ± SD (kg)
|
67.46 ± 14.23
|
|
BMI, mean ± SD (kg/m2)
|
24.33 ± 4.62
|